Share:
Peer-Reviewed Publication
Elife2017;6August 15, 2017Journal Article

Deconstruction of the beaten Path-Sidestep interaction network provides insights into neuromuscular system development.

Hanqing Li1, Ash Watson2,3, Agnieszka Olechwier4, Michael Anaya1, Siamak K Sorooshyari5, Dermott P Harnett2,3, Hyung-Kook Peter Lee1, Jost Vielmetter1, Mario A Fares2,6, K Christopher Garcia7,8, Engin Özkan4, Juan-Pablo Labrador2,3, Kai Zinn1
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, United States.
2Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland.
3Institute of Neuroscience, Trinity College Dublin, University of Dublin, Dublin, Ireland.
4Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, United States.
5Ellipsis Health, San Francisco, United States.
6Department of Abiotic Stress, Group of Integrative and Systems Biology, Instituto de Biología Molecular y Celular de Plantas (CSIC-Universidad Politécnica de Valencia), Valencia, Spain.
7Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, United States.
8Department of Structural Biology, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, United States.

Abstract

An 'interactome' screen of all Drosophila cell-surface and secreted proteins containing immunoglobulin superfamily (IgSF) domains discovered a network formed by paralogs of Beaten Path (Beat) and Sidestep (Side), a ligand-receptor pair that is central to motor axon guidance. Here we describe a new method for interactome screening, the Bio-Plex Interactome Assay (BPIA), which allows identification…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.